Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPEN liposomal amphotericin B pharmacokinetics in obese adults
NL-OMON47120Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amphotericin b in invasive mycoses and aspergillosis (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: AUC0-inf of AmBisome, Cmax and 3 more. Started Mar 2018; status: active, not recruiting.
02
Drugs
amphotericin b
03
Conditions
invasive mycosesaspergillosis
Beyond the preview
Go deeper on NL-OMON47120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47120.